New York Tech Media
  • News
  • FinTech
  • AI & Robotics
  • Cybersecurity
  • Startups & Leaders
  • Venture Capital
No Result
View All Result
  • News
  • FinTech
  • AI & Robotics
  • Cybersecurity
  • Startups & Leaders
  • Venture Capital
No Result
View All Result
New York Tech Media
No Result
View All Result
Home News

Pfizer says its antiviral pill reduces hospitalizations and deaths from COVID-19

New York Tech Editorial Team by New York Tech Editorial Team
November 5, 2021
in News
0
Pfizer says its antiviral pill reduces hospitalizations and deaths from COVID-19
Share on FacebookShare on Twitter

Pfizer’s antiviral pill is highly effective at preventing people who catch COVID-19 from becoming seriously ill, the company said today in a press release. A clinical trial showed that the pill, which has the brand name Paxlovid, cut the risk of hospitalization and death by 89 percent for adults at high risk of developing severe disease when it was given within three days of symptoms appearing.

The company said it plans to submit its data to the Food and Drug Administration (FDA) for emergency use authorization “as soon as possible.”

This is the second effective anti-COVID-19 pill. The first, developed by pharmaceutical company Merck, cut risk of hospitalization and death by about half. The United Kingdom’s health agency authorized the Merck pill on Thursday, and the FDA’s advisory committee is scheduled to discuss it on November 30th.

Pfizer tested its drug in a study that included 1,219 adults who tested positive for COVID-19, had mild or moderate symptoms, and who had at least one underlying medical condition that would put them at risk for a severe case of the disease (like diabetes or a lung condition). Participants were randomly assigned to either take a course of placebo pills or the active drug. Three people in the active drug group were hospitalized and none died. In the placebo group, 27 people were hospitalized and seven died. The data was announced in a press release and has not been published in a scientific journal.

The Pfizer treatment works by stopping the coronavirus from making copies of itself inside cells. It includes 30 pills taken over five days. Merck’s, which works in a similar way, requires 40 pills taken over five days. Both are cheaper than treatments like monoclonal antibodies, which also can keep people from becoming seriously ill. They’re also logistically easier to use — pills can be taken at home, while antibody treatments are given through an infusion at a health center.

The challenge with antiviral treatments like the Pfizer pill is ensuring that people are able to access them in the short window when they’re most effective. If people aren’t able to get a COVID-19 test result or make it to a doctor within the first few days after they start feeling sick, they likely won’t be able to get the same benefits from the drug.

Medications taken after someone gets sick also aren’t a replacement for vaccines, which can prevent people from getting sick in the first place. But antiviral pills are an important tool to fight COVID-19. “I think getting an oral pill that can inhibit viral replication — that can inhibit this virus — is going to be a real game changer,” former FDA commissioner Scott Gottlieb told CNN in October.

Credit: Source link

Previous Post

Twitter hacker charged in sim swapping, cryptocurrency scheme

Next Post

E-scooter startup Lime raises $523 mln, eyes going public in 2022

New York Tech Editorial Team

New York Tech Editorial Team

New York Tech Media is a leading news publication that aims to provide the latest tech news, fintech, AI & robotics, cybersecurity, startups & leaders, venture capital, and much more!

Next Post
E-scooter startup Lime raises $523 mln, eyes going public in 2022

E-scooter startup Lime raises $523 mln, eyes going public in 2022

  • Trending
  • Comments
  • Latest
Meet the Top 10 K-Pop Artists Taking Over 2024

Meet the Top 10 K-Pop Artists Taking Over 2024

March 17, 2024
Panther for AWS allows security teams to monitor their AWS infrastructure in real-time

Many businesses lack a formal ransomware plan

March 29, 2022
Zach Mulcahey, 25 | Cover Story | Style Weekly

Zach Mulcahey, 25 | Cover Story | Style Weekly

March 29, 2022
How To Pitch The Investor: Ronen Menipaz, Founder of M51

How To Pitch The Investor: Ronen Menipaz, Founder of M51

March 29, 2022
Japanese Space Industry Startup “Synspective” Raises US $100 Million in Funding

Japanese Space Industry Startup “Synspective” Raises US $100 Million in Funding

March 29, 2022
UK VC fund performance up on last year

VC-backed Aerium develops antibody treatment for Covid-19

March 29, 2022
Startups On Demand: renovai is the Netflix of Online Shopping

Startups On Demand: renovai is the Netflix of Online Shopping

2
Robot Company Offers $200K for Right to Use One Applicant’s Face and Voice ‘Forever’

Robot Company Offers $200K for Right to Use One Applicant’s Face and Voice ‘Forever’

1
Menashe Shani Accessibility High Tech on the low

Revolutionizing Accessibility: The Story of Purple Lens

1

Netgear announces a $1,500 Wi-Fi 6E mesh router

0
These apps let you customize Windows 11 to bring the taskbar back to life

These apps let you customize Windows 11 to bring the taskbar back to life

0
This bipedal robot uses propeller arms to slackline and skateboard

This bipedal robot uses propeller arms to slackline and skateboard

0
Eldad Tamir

AI vs. Traditional Investing: How FINQ’s SEC RIA License Signals a New Era in Wealth Management

March 17, 2025
Overcoming Payment Challenges: How Waves Audio Streamlined Transactions with BridgerPay

Overcoming Payment Challenges: How Waves Audio Streamlined Transactions with BridgerPay

March 16, 2025
Arvatz and Iyer

PointFive and Emertel Forge Strategic Partnership to Elevate Enterprise FinOps in ANZ

March 13, 2025
Canditech website

Canditech is Revolutionizing Hiring With Their New Product

March 9, 2025
Magnus Almqvist, new CEO of Exberry

Exberry Appoints Magnus Almqvist as CEO to Drive Next Phase of Strategic Growth

March 5, 2025
Expert Family Law Firms in New York: Your Essential Guide to Legal Help

Expert Family Law Firms in New York: Your Essential Guide to Legal Help

March 3, 2025

Recommended

Eldad Tamir

AI vs. Traditional Investing: How FINQ’s SEC RIA License Signals a New Era in Wealth Management

March 17, 2025
Overcoming Payment Challenges: How Waves Audio Streamlined Transactions with BridgerPay

Overcoming Payment Challenges: How Waves Audio Streamlined Transactions with BridgerPay

March 16, 2025
Arvatz and Iyer

PointFive and Emertel Forge Strategic Partnership to Elevate Enterprise FinOps in ANZ

March 13, 2025
Canditech website

Canditech is Revolutionizing Hiring With Their New Product

March 9, 2025

Categories

  • AI & Robotics
  • Benzinga
  • Cybersecurity
  • FinTech
  • New York Tech
  • News
  • Startups & Leaders
  • Venture Capital

Tags

3D bio-printing acoustic AI Allseated B2B marketing Business carbon footprint climate change coding Collaborations Companies To Watch consumer tech cryptocurrency deforestation drones earphones Entrepreneur Fetcherr Finance Fintech food security Investing Investors investorsummit israelitech Leaders LinkedIn Leaders Metaverse news OurCrowd PR Real Estate reforestation software start- up startupnation Startups Startups On Demand startuptech Tech Tech leaders technology UAVs Unlimited Robotics VC
  • Contact Us
  • Privacy Policy
  • Terms and conditions

© 2024 All Rights Reserved - New York Tech Media

No Result
View All Result
  • News
  • FinTech
  • AI & Robotics
  • Cybersecurity
  • Startups & Leaders
  • Venture Capital

© 2024 All Rights Reserved - New York Tech Media